Transcatheter closure of secundum atrial septal defects (ASD), a common congenital heart abnormality in children, is a minimally invasive procedure that is a safe alternative to traditional surgery at ...

Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained Japanese MHW approval for its dedicated Atrial Septal Defect Closure Device. The ...

It looks like a yo-yo, but it can stretch, flatten out, "swell up," or even "self-center," depending on what it needs to do to adjust itself to plug holes in the heart that make up some of the most ...

Intuitive Surgical ISRG recently announced that the FDA has granted 510(k) clearance for the da Vinci 5 system to be used in ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market for Heart Defect Closure Devices - 2016 (Forecasted to 2022) - MedCore" report to their offering. As of ...

Editor's Note: This article is made possible through a sponsored content partnership with New Hanover Regional Medical Center. Structural heart disease includes conditions in which the heart’s valves, ...

The Structural Heart Occlusion Devices market presents opportunities in offering minimally invasive solutions for congenital heart defects, enhancing recovery. Insights on market trends, competitive ...

Minimally invasive surgery for congenital heart disease in paediatric patients is a broad concept; the aim is to reduce the trauma of the operation at each stage of management Minimally invasive ...

LONDON--(BUSINESS WIRE)--The global heart defect closure devices market research report by Technavio predicts the market to post a CAGR of more than 29% during the period 2019-2023. A key driver for ...

A less invasive procedure for treating a congenital heart defect in children is a safe alternative to traditional surgery with no five-year difference in risk of death and is associated with a 62 ...